✦ LIBER ✦

Cytotoxic drugs in an avian urate microcrystal arthritis

✍ Scribed by George L. Floersheim; Kay Brune; Karl Seiler

Publisher: SP Birkhäuser Verlag Basel
Year: 1973
Tongue: English
Weight: 360 KB
Volume: 3
Category: Article
ISSN: 1420-908X
DOI: 10.1007/bf02023847

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Colchicine in avian sodium urate and cal

Colchicine in avian sodium urate and calcium pyrophosphate microcrystal arthritis

✍ George L. Floersheim; Kay Brune; Karl Seiler 📂 Article 📅 1973 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 280 KB

Sulphasalazine in arthritis — an old dru

Sulphasalazine in arthritis — an old drug rediscovered

✍ A. J. Taggart 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 414 KB

The avian microcrystal arthritis IV. The

The avian microcrystal arthritis IV. The impact of sodium salicylate, acetaminophen and colchicine on leukocyte invasion and enzyme liberation in vivo

✍ Kay Brune; Markus Glatt 📂 Article 📅 1974 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 557 KB

Cytotoxic drug treatment of reactive amy

Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency

✍ M. Ahlmen; J. Ahlmen; C. Svalander; H. Bucht 📂 Article 📅 1987 🏛 Springer 🌐 English ⚖ 675 KB

Limitation of activity in an acute model

Limitation of activity in an acute model of arthritis: Effect of drug treatment

✍ M. L. Bliven; J. D. Eskra; I. G. Otterness 📂 Article 📅 1997 🏛 SP Birkhäuser Verlag Basel 🌐 English ⚖ 162 KB

Oestrogen potentiates topoisomerase-II-m

Oestrogen potentiates topoisomerase-II-mediated cytotoxicity in an activated subpopulation of human breast cancer cells: Implications for cytotoxic drug resistance in solid tumours

✍ R. J. Epstein; P. J. Smith; J. V. Watson; C. Waters; N. M. Bleehen 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 French ⚖ 811 KB

Primary resistance to chemotherapeutic agents is a major problem in the management of advanced cancer. By using oestrogen to modulate the topoisomerase II content of T-47D human breast cancer cells, we show here that cell subpopulations resistant to the topoisomerase-ll-interactive drug VP 16 (etopo